Taiwan · Delayed Price · Currency is TWD Pharmosa Biopharm Statistics
Total Valuation
TPEX:6875 has a market cap or net worth of TWD 4.31 billion. The enterprise value is 3.72 billion.
| Market Cap | 4.31B |
| Enterprise Value | 3.72B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6875 has 129.18 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 129.18M |
| Shares Outstanding | 129.18M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 9.93% |
| Owned by Institutions (%) | 2.03% |
| Float | 76.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 80.83 |
| PB Ratio | 3.16 |
| P/TBV Ratio | 3.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 69.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.45, with a Debt / Equity ratio of 0.25.
| Current Ratio | 12.45 |
| Quick Ratio | 11.56 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.68 |
| Interest Coverage | -193.71 |
Financial Efficiency
Return on equity (ROE) is -22.83% and return on invested capital (ROIC) is -14.41%.
| Return on Equity (ROE) | -22.83% |
| Return on Assets (ROA) | -13.77% |
| Return on Invested Capital (ROIC) | -14.41% |
| Return on Capital Employed (ROCE) | -23.91% |
| Weighted Average Cost of Capital (WACC) | 4.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 40 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 1.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.36% in the last 52 weeks. The beta is 0.19, so TPEX:6875's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -25.36% |
| 50-Day Moving Average | 35.23 |
| 200-Day Moving Average | 42.24 |
| Relative Strength Index (RSI) | 44.66 |
| Average Volume (20 Days) | 76,223 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6875 had revenue of TWD 53.38 million and -351.33 million in losses. Loss per share was -2.71.
| Revenue | 53.38M |
| Gross Profit | 10.59M |
| Operating Income | -406.79M |
| Pretax Income | -351.33M |
| Net Income | -351.33M |
| EBITDA | -378.34M |
| EBIT | -406.79M |
| Loss Per Share | -2.71 |
Balance Sheet
The company has 933.28 million in cash and 340.89 million in debt, with a net cash position of 592.39 million or 4.59 per share.
| Cash & Cash Equivalents | 933.28M |
| Total Debt | 340.89M |
| Net Cash | 592.39M |
| Net Cash Per Share | 4.59 |
| Equity (Book Value) | 1.37B |
| Book Value Per Share | 10.64 |
| Working Capital | 934.45M |
Cash Flow
In the last 12 months, operating cash flow was -319.30 million and capital expenditures -179.28 million, giving a free cash flow of -498.58 million.
| Operating Cash Flow | -319.30M |
| Capital Expenditures | -179.28M |
| Depreciation & Amortization | 22.89M |
| Net Borrowing | -18.68M |
| Free Cash Flow | -498.58M |
| FCF Per Share | -3.86 |
Margins
| Gross Margin | 19.84% |
| Operating Margin | -762.03% |
| Pretax Margin | -658.14% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6875 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | -0.04% |
| Earnings Yield | -8.14% |
| FCF Yield | -11.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |